19-11007932-C-T

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_003072.5(SMARCA4):​c.2032C>T​(p.Gln678*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,474 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

SMARCA4
NM_003072.5 stop_gained

Scores

3
3
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 1.65
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-11007932-C-T is Pathogenic according to our data. Variant chr19-11007932-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 486489.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA4NM_001387283.1 linkc.2032C>T p.Gln678* stop_gained Exon 14 of 36 ENST00000646693.2 NP_001374212.1
SMARCA4NM_003072.5 linkc.2032C>T p.Gln678* stop_gained Exon 14 of 35 ENST00000344626.10 NP_003063.2 P51532-1A7E2E1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA4ENST00000646693.2 linkc.2032C>T p.Gln678* stop_gained Exon 14 of 36 NM_001387283.1 ENSP00000495368.1 Q9HBD4
SMARCA4ENST00000344626.10 linkc.2032C>T p.Gln678* stop_gained Exon 14 of 35 1 NM_003072.5 ENSP00000343896.4 P51532-1
SMARCA4ENST00000643549.1 linkc.2032C>T p.Gln678* stop_gained Exon 14 of 35 ENSP00000493975.1 A0A2R8Y4P4
SMARCA4ENST00000541122.6 linkc.2032C>T p.Gln678* stop_gained Exon 15 of 35 5 ENSP00000445036.2 P51532-4
SMARCA4ENST00000643296.1 linkc.2032C>T p.Gln678* stop_gained Exon 14 of 34 ENSP00000496635.1 P51532-4
SMARCA4ENST00000644737.1 linkc.2032C>T p.Gln678* stop_gained Exon 14 of 34 ENSP00000495548.1 P51532-4
SMARCA4ENST00000589677.5 linkc.2032C>T p.Gln678* stop_gained Exon 15 of 35 5 ENSP00000464778.1 P51532-3
SMARCA4ENST00000643995.1 linkc.1444C>T p.Gln482* stop_gained Exon 11 of 32 ENSP00000496004.1 A0A2R8YGG3
SMARCA4ENST00000644963.1 linkc.676C>T p.Gln226* stop_gained Exon 7 of 28 ENSP00000495599.1 A0A2R8YG32
SMARCA4ENST00000644065.1 linkc.757C>T p.Gln253* stop_gained Exon 7 of 27 ENSP00000493615.1 A0A2R8Y440
SMARCA4ENST00000642350.1 linkc.517C>T p.Gln173* stop_gained Exon 6 of 27 ENSP00000495355.1 A0A2R8Y6N0
SMARCA4ENST00000643857.1 linkc.385C>T p.Gln129* stop_gained Exon 5 of 25 ENSP00000494159.1 A0A2R8Y526

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461474
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
727056
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Rhabdoid tumor predisposition syndrome 2 Pathogenic:1
Oct 20, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Loss-of-function variants in SMARCA4 are known to be pathogenic (PMID: 24658001, 24658002). This sequence change creates a premature translational stop signal (p.Gln678*) in the SMARCA4 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in the germline of individuals with SMARCA4-related disease. ClinVar contains an entry for this variant (Variation ID: 486489). For these reasons, this variant has been classified as Pathogenic. -

Hereditary cancer-predisposing syndrome Pathogenic:1
May 10, 2017
Ambry Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.Q678* pathogenic mutation (also known as c.2032C>T), located in coding exon 13 of the SMARCA4 gene, results from a C to T substitution at nucleotide position 2032. This changes the amino acid from a glutamine to a stop codon within coding exon 13. This mutation has been reported in the homozygous state in an atypical teratoid/rhabdoid brain tumor biopsied from a 9-month old male; authors were unable to perform germline testing for the patient or the parents (Hasselblatt M et al. Am. J. Surg. Pathol., 2011 Jun;35:933-5). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.65
CADD
Pathogenic
37
DANN
Uncertain
1.0
Eigen
Pathogenic
0.71
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Uncertain
0.81
D
Vest4
0.94
GERP RS
5.6
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1555771571; hg19: chr19-11118608; API